Review
Open access
Sep 2026
Neuroinflammation and Graft Survival in Pluripotent Stem Cell‐Derived Therapies for the Central Nervous System
Recently, Japan conditionally approved the first cell transplantation therapy for a central nervous system disorder using induced pluripotent stem cells as the source of dopaminergic progenitors to treat Parkinson's disease. This milestone was achieved almost 40 years after the first cell therapy trial for Parkinson's...
Lucía Sánchez, C. Rodriguez, F. Pitossi
· Journal of Neurochemistry · 0 citations